Frontiers Production OfficeBy Wang Y, Meilu D, Qi S, Yufei T, Song G, Susu H, Haotian W, Tingting Z, Chao W, Fenggang H and Xiaoling Y (2025) Front. Immunol. 16:1582308. doi: 10.3389/fimmu.2025.1582308
Due to a production mistake, there was a mistake in Table 3 and Table 5 as published. The tables were swapped. The corrected Table 3 and Table 5 appear below.
Table 3. MR results of exposure factors and outcomes (left hand grip strength).
Table 5. MR results of exposure factors and outcomes (limb muscle mass).
The publisher apologizes for the error and the original version of this article has been updated.
Keywords: sarcopenia, immune, nutrition, advanced colorectal cancer, fruquintinib, mendelian randomization study
Citation: Frontiers Production Office (2025) Correction: The impact of sarcopenia on prognosis and fruquintinib efficacy in advanced colorectal cancer: a retrospective and mendelian randomization study. Front. Immunol. 16:1671178. doi: 10.3389/fimmu.2025.1671178
Received: 22 July 2025; Accepted: 22 July 2025;
Published: 05 August 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn